Propagenix is a leading biotechnology brand specialized in the development and commercialization of innovative technologies for cell therapy, tissue models, and discovery science. With a focus on expanding and differentiating tissue-resident epithelial stem cells, Propagenix is dedicated to advancing biomedical research and improving human healthcare. Their cutting-edge technology enables the creation of new and more effective drugs, personalized diagnostics, and cell therapies.

The team at Propagenix consists of experts in the field who thrive on scientific excellence, fostering a culture of innovation, open communication, collaboration, and a fast-paced work environment. Their vision is to revolutionize the field of regenerative medicine by harnessing the power of stem cells. Propagenix has partnered with renowned institutions and organizations such as STEMCELL Technologies, Georgetown University, Yale University, and the University of Colorado.

They have a robust portfolio of technology publications and research programs, demonstrating their commitment to staying at the forefront of biomedical advancements. Contact Propagenix today to learn more about their groundbreaking technologies and how they are shaping the future of regenerative medicine